News | January 16, 2007

Invitrogen To Partner With Wave Biotech, LLC To Supply Media-Filled Disposable Bioreactor Bags

Carlsbad, CA & Somerset, NJ - Invitrogen Corporation, a provider of essential life science technologies for disease research and drug discovery, and Wave Biotech, LLC, a research-based company that develops and manufactures innovative process equipment for the pharmaceutical and biotechnology industries, today announced they entered into a partnership to supply media-filled disposable bioreactors. Under the agreement, Invitrogen Corporation will offer its GIBCO brand cell culture media products to Wave Bioreactor users in filled Cellbag brand disposable bioreactor bags.

Invitrogen will offer both standard and custom media products in the standard O-series Cellbag format. Disposable bioreactors and Cellbags are easily customized to suit specific cell culture process needs for research, development or cGMP manufacturing operations. Media-filled Wave O-series Cellbags are available for ordering through Invitrogen's e-commerce and custom product channels.

"This partnership creates a tremendously convenient solution for bioreactor users and will substantially reduce customer prep time and the inherent contamination risks and raw materials tracking issues associated with self-filling of bioreactor vessels," said Nicolas Barthelemy, Senior Vice President of Invitrogen's Cell Culture Systems division. "Invitrogen has already received many customer requests for filled bags, and is pleased to offer this increased convenience to our customers."

"The Wave Bioreactor system is differentiated from the rest of the bioreactor market by its commitment to the highest standards of quality and end-user convenience," said Daniella Kranjac, Vice President, Sales and Marketing at Wave Biotech. "Invitrogen's commitment to making its quality products readily accessible to Wave Bioreactor customers, and its knowledge of the specialized needs of research and bioproduction customers, were key factors in our selection of Invitrogen as our partner for this endeavor."

SOURCE: Invitrogen Corporation and Wave Biotech, LLC